OVER 4 TIMES MORE LIKELY TO LOSE YOUR SIGHT FROM OZEMPIC THAN OTHER WEIGHT LOSS DRUGS
Wegovy, Ozempic linked with sight-threatening eye disorder in study
Wegovy and Novo's diabetes drugs Ozempic and Rybelsus all contain the same active ingredient, semaglutide, and belong to a class of medications known as GLP1 receptor agonists.
The rate of the eye problem known as nonarteritic anterior ischemic optic neuropathy, or NAION, was 8.9% for those taking semaglutide for type 2 diabetes, compared with 1.8% for patients taking non-GLP-1 diabetes medications, researchers reported in JAMA Ophthalmology.
Among those prescribed semaglutide for overweight or obesity, the rate of the eye condition was 6.7%, versus 0.8% for those receiving other types of medications for weight reduction.
https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-ozempic-linked-with-sight-threatening-eye-disorder-study-2024-07-03/
Oh yeah! The wonder drug
- Forums
- Science & Medicine
- News: Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
News: Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online